The FDA has approved niraparib and abiraterone acetate (Akeega, Janssen) plus prednisone for the treatment of certain patients with castration-sensitive prostate cancer (CSPC). Specifically, the ...

Abiraterone plus androgen deprivation therapy (ADT), with prednisolone or prednisone can be used, within its marketing authorisation, as an option to treat newly diagnosed high-risk hormone‑sensitive ...

Abiraterone (generic) is indicated 'with prednisone or prednisolone for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with ...

In a significant policy reversal, the National Institute for Health and Care Excellence (NICE) has recommended abiraterone for adults with newly diagnosed high-risk metastatic prostate cancer, ...

Clinical study design and research outcomes. (Bottom left) Low dose abiraterone acetate (AA) demonstrated reduced PSA levels-a marker of tumour activity. (Bottom middle) Safety profile suggested that ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from ...

Triple therapy with darolutamide vs abiraterone for metastatic hormone-sensitive prostate cancer is associated with better clinical outcomes. Triplet therapy that includes darolutamide vs abiraterone ...

Please provide your email address to receive an email when new articles are posted on . Men treated with enzalutamide lived about a month longer than those who received abiraterone acetate. Men who ...

1 Department of Urology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China 2 Human Anatomy and Tissue Embryo Experiment Center, Chengdu ...

During a recent Polygon meeting, I realized something: I have no idea how to pronounce Balatro, the name of developer LocalThunk’s incredible roguelite poker game that’s occupied every one of my ...